Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by antinuclear antibodies (ANAs). Epstein-Barr virus (EBV) infection has been epidemiologically associated with SLE, yet its role in pathogenesis remains incompletely defined. Here, we developed an EBV-specific single-cell RNA-sequencing platform and used it to demonstrate that EBV infection reprograms autoreactive antinuclear antigen B cells to drive autoimmunity in SLE. We demonstrated that, in SLE, EBV + B cells are predominantly CD27 + CD21 low memory B cells that are present at increased frequencies and express ZEB2 , TBX21 (T-bet), and antigen-presenting cell transcriptional pathways. Integrative analysis of chromatin immunoprecipitation sequencing (ChIP-seq), assay for transposase-accessible chromatin sequencing (ATAC-seq), and RNA polymerase II occupancy data revealed EBV nuclear antigen 2 (EBNA2) binding at the transcriptional start sites and regulatory regions of CD27 , ZEB2 , and TBX21 , as well as the antigen-presenting cell genes demonstrated to be up-regulated in SLE EBV + B cells. We expressed recombinant antibodies from SLE EBV + B cells and demonstrated that they bind prototypical SLE nuclear autoantigens, whereas those from healthy individuals do not. We further found that SLE EBV + B cells can serve as antigen-presenting cells to drive activation of T peripheral helper cells with concomitant activation of related EBV − antinuclear double-negative 2 B cells and plasmablasts. Our results provide a mechanistic basis for EBV being a driver of SLE through infecting and reprogramming nuclear antigen-reactive B cells to become activated antigen-presenting cells with the potential to promote systemic disease–driving autoimmune responses.
Inflammatory bowel disease (IBD) is one of the most prevalent chronic inflammations of the gastrointestinal tract (GIT). The gut microbial population, the cytokine milieu, the aryl hydrocarbon receptor (AHR) expressed by immune and nonimmune cells and the intrinsic pathway of Th-cell differentiation are implicated in the immunopathology of IBD. AHR activation requires a delicate balance between regulatory and effector T-cells; loss of this balance can cause local gut microbial dysbiosis and intestinal inflammation. Thus, the study of the gut microbiome in association with AHR provides critical insights into IBD pathogenesis and interventions. This review will focus on the recent advancements to form conceptional frameworks on the benefits of AHR activation by commensal gut bacteria in IBD.
Summary paragraph: Multiple sclerosis (MS) is a chronic autoimmune disease targeting the central nervous system (CNS). MS develops almost exclusively in individuals previously infected with Epstein–Barr virus (EBV) 1 , yet the mechanisms linking EBV infection to MS pathogenesis remain incompletely defined. Here we characterized EBV-infected B cells in MS and demonstrated that EBV directly infects autoreactive anti-CNS antigen B cells and reprograms them into pro-inflammatory antigen-presenting cells (APCs). EBV⁺ B cells in MS were enriched within the CD27⁺CD21 low memory B-cell subset and exhibited upregulated B cell activation and APC transcriptional programs. Recombinant antibodies derived from MS blood and cerebrospinal fluid (CSF) EBV⁺ B cells bound brain tissue, and several cross-bound both MS-associated autoantigens and Epstein-Barr virus nuclear antigen-1 (EBNA1). In vitro , EBV⁺ B cells functioned as APCs that stimulated T peripheral helper cells, with associated activation of EBV⁻ anti-CNS antigen B cells. Collectively, these findings support a mechanistic framework in which EBV infects and transcriptionally reprograms autoreactive anti-CNS antigen B cells into APCs that drive pathogenic anti-CNS antigen T cell and EBV - B cell responses in MS.
Background and objectives:A selective medium is required for isolation of Burkholderia pseudomallei from soil. The present study aimed to develop an easy to prepare selective media by modifying MacConkey agar medium for improved isolation of B. pseudomallei from soil. Materials and methods: The media was prepared by using commercially available MacConkey agar as the basal medium and incorporating it with 4% glycerol and four antimicrobials namely vancomycin, amphotericin B, gentamicin and colistin at a concentration of 2.5 mg/L, 1 mg/L, 5 mg/L and 10 mg/L respectively. The media was initially optimized for growth of B. pseudomallei by addition of 100 organisms/plate of B. pseudomallei and ATCC strains of Gram negative and Gram positive bacteria. Sterile and unsterile soils were spiked with graded concentration (1x106 to 1x101 CFU/gm of soil) of B. pseudomallei and other clinical and saprophytic Gram negative organisms and cultured on MacConkey, Ashdown and modified MacConkey media after enrichment in Ashdown broth. Growth of B. pseudomallei in the three media was compared. The newly devised media was termed as - Modified MacConkey agar for Burkholderia (MMB media). Results: Culture of supernatant from spiked sterile soil after enrichment showed equivalent isolation of B. pseudomallei on MMB and Ashdown’s media and there was 100% inhibition of Klebsiella pneumoniae, Escherichia coli and Pseudomonas aeruginosa on MMB medium. Almost similar inhibition of Comamonas testosteroni, Aeromonas salmonicida and Burkholderia cepacia was observed on both MMB and Ashdown’s media. Culture of sterile soil seeded with different concentrations of P. aeruginosa showed no growth in MMB media. But there was growth of P. aeruginosa when sterile soil samples spiked with 1x106 to 1x103 CFU of P. aeruginosa were cultured in Ashdown media. When unsterile soil was seeded with graded concentration of B. pseudomallei, the colony count of this bacterium gradually declined in all three medium with decreased spiking concentrations. Growth of other soil organisms was less in MMB media compared to other two media. Conclusion: The newly devised MMB media is selective and easy to prepare for the detection of B. pseudomallei from soil. IMC J Med Sci. 2024; 18(1):011. DOI: https://doi.org/10.55010/imcjms.18.011 *Correspondence:Md. Shariful Alam Jilani, Department of Microbiology, Ibrahim Medical College, 1/A Ibrahim Sarani, Segun Bagicha, Dhaka-1000, Bangladesh. Email: jilanimsa@gmail.com